Mirati Therapeutics, Inc.

NORTHERN TRUST CORP

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/13/2024

Shares

253,930

Value ($000)

14,918

Weight

0.0%

2019 Q4 - 2023 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/13/2024	14,918	0.0%	253,930	12/31/2023
2023 Q3	11/13/2023	10,488	0.0%	240,780	9/30/2023
2023 Q2	8/11/2023	7,759	0.0%	214,758	6/30/2023
2023 Q1	5/15/2023	7,570	0.0%	203,607	3/31/2023
2022 Q4	2/13/2023	8,792	0.0%	194,033	12/31/2022
2022 Q3	11/14/2022	13,795	0.0%	197,519	9/30/2022
2022 Q2	8/12/2022	12,872	0.0%	191,737	6/30/2022
2022 Q1	5/13/2022	16,462	0.0%	200,214	3/31/2022
2021 Q4	2/8/2022	29,107	0.0%	198,430	12/31/2021
2021 Q3	11/15/2021	33,561	0.0%	189,701	9/30/2021
2021 Q2	8/13/2021	37,582	0.0%	232,660	6/30/2021
2021 Q1	5/12/2021	81,362	0.0%	474,970	3/31/2021
2020 Q4	2/11/2021	108,738	0.0%	495,072	12/31/2020
2020 Q3	11/16/2020	73,610	0.0%	443,297	9/30/2020
2020 Q2	8/14/2020	52,790	0.0%	462,378	6/30/2020
2020 Q1	5/14/2020	29,264	0.0%	380,711	3/31/2020
2019 Q4	2/14/2020	44,666	0.0%	346,628	12/31/2019